AbbraTech is a startup based in the United States.
AbbraTech develops a recombinant antibody discovery platform that enables the identification and engineering of antibodies against challenging disease targets using its EPIVOLVEsm technology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.